Clinical Trial Update: Exercise and Low-Dose Rapamycin in Older Adults With CAD:Cardiac Rehabilitation And Rapamycin in Elderly (CARE) Trial [Phase 1]

View source ↗

Summary

Mayo Clinic conducted the CARE Trial, a Phase 1 study assessing exercise plus low-dose rapamycin in older adults with coronary artery disease; the study has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Rapamycin (sirolimus)

Snippet

Sponsor: Mayo Clinic | Conditions: Aging, CAD | Phase 1 | Status: COMPLETED